4//SEC Filing
PHARMACYCLICS INC 4
Accession 0001209191-14-017880
CIK 0000949699operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:33 PM ET
Size
14.6 KB
Accession
0001209191-14-017880
Insider Transaction Report
Form 4
Sjovall Boultbee Paula S
EVP, Sales and Marketing
Transactions
- Exercise/Conversion
Common Stock
2014-03-04$25.94/sh+13,747$356,597→ 15,486 total - Sale
Common Stock
2014-03-04$137.07/sh−13,747$1,884,330→ 1,739 total - Sale
Common Stock
2014-03-05$140.75/sh−6,253$880,115→ 1,739 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-03-05−6,253→ 180,000 totalExercise: $25.94From: 2012-04-17Exp: 2022-04-17→ Common Stock (6,253 underlying) - Exercise/Conversion
Common Stock
2014-03-05$25.94/sh+6,253$162,203→ 7,992 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-03-04−13,747→ 186,253 totalExercise: $25.94From: 2012-04-17Exp: 2022-04-17→ Common Stock (13,747 underlying)
Holdings
- 406(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The option shares vest 25% on each of April 11, 2013, April 11, 2014, April 11, 2015 and April 11, 2016, subject to satisfaction of certain performance criteria with respect to each vesting period. Such performance criteria is to be determined and approved by the Compensation Committee.
Documents
Issuer
PHARMACYCLICS INC
CIK 0000949699
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000949699
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:33 PM ET
- Size
- 14.6 KB